Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/ANNEXON-INC-110038737/nieuws/Annexon-Inc-Rapporteert-Fase-2-Klinische-Onderzoeksresultaten-die-aantonen-dat-upstream-remming-va-40670460/?utm_source=whatsapp&utm_medium=social&utm_campaign=share